In a market where conviction can turn on a dime faster than sentiment, NEOS Investments believes that being neutral can, in fact, be a positive. The firm officially launched the NEOS Long/Short Equity Income ETF (BATS:NLSI) on Dec 11, as…
Transocean Ltd (NYSE:RIG) shares slipped Tuesday as energy stocks came under pressure on hopes for a Russia‑Ukraine ceasefire and forecasts of unusually warm weather weighing on oil and natural gas prices. Transocean shares are sliding. Why are RIG shares down?…
PayPal Holdings Inc (NASDAQ:PYPL) shares are moving higher Tuesday after the company announced plans to establish a bank, which could enhance its ability to provide business lending solutions. PayPal Holdings stock is gaining positive traction. What’s pushing PYPL stock higher? What…
U.S. Senator Elizabeth Warren (D-Mass.) on Monday escalated pressure on DeFi tied to President Donald Trump, demanding a national security probe just as Senate negotiations over a crypto market structure bill slipped into January. Warren Seeks Probe Into Trump-Linked DeFi…
Investors with a lot of money to spend have taken a bullish stance on Arista Networks (NYSE:ANET). And retail traders should know. We noticed this today when the trades showed up on publicly available options history that we track here…
In the current market session, Micron Technology Inc. (NASDAQ:MU) stock price is at $231.42, after a 2.56% drop. However, over the past month, the company's stock increased by 1.28%, and in the past year, by 122.73%. Shareholders might be interested…
Thematic investors are split between two big future bets: robotics and electric vehicles. But for now, each has a different engine driving it. Robotics is gaining traction with politicians in Washington. Meanwhile, priority attention is still focused on car sales…
Tilray Brands Inc (NASDAQ:TLRY) shares are in the spotlight Tuesday, surging over 20% amid continued chatter about potential marijuana reclassification. Tilray Brands stock is showing exceptional strength. What’s behind TLRY gains? What To Know: The move in Tilray shares appears to…
Monte Rosa Therapeutics Inc. (NASDAQ:GLUE) shared interim data from an ongoing Phase 1/2 clinical study evaluating MRT-2359 in combination with enzalutamide in heavily pretreated patients with metastatic castration-resistant prostate cancer (mCRPC). The Phase 1/2 study evaluated 0.5 mg and 0.75…
Year-end trading on Wall Street follows a familiar pattern, and the same question resurfaces once again: will the Santa Claus rally make an appearance? The stretch between Christmas and the first trading days of January is historically known for the…